Pacanowski J - Search Results

1

Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient.

Paccoud O, Alain S, Gozlan J, Jarboui S, Boutolleau D, Hantz S, Battipaglia G, Paviglianiti A, Duléry R, Malard F, Médiavilla C, Sestili S, Gaugler B, Meynard JL, Pacanowski J, Mohty M, Brissot E. Paccoud O, et al. Among authors: pacanowski j. Curr Res Transl Med. 2022 May;70(2):103329. doi: 10.1016/j.retram.2021.103329. Epub 2022 Jan 10. Curr Res Transl Med. 2022. PMID: 35021130 No abstract available.

2

Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).

Suzan-Monti M, Celse M, Vilotitch A, Demoulin B, Dray-Spira R, Yéni P, Lert F, Spire B; ANRS VESPA2 study group. Suzan-Monti M, et al. AIDS Behav. 2018 Oct;22(10):3264-3272. doi: 10.1007/s10461-018-2077-6. AIDS Behav. 2018. PMID: 29512033

3

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

INSIGHT START Study Group; Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. INSIGHT START Study Group, et al. N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20. N Engl J Med. 2015. PMID: 26192873 Free PMC article. Clinical Trial.

4

Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen.

Lacombe K, Pacanowski J, Meynard JL, Trylesinski A, Girard PM. Lacombe K, et al. Among authors: pacanowski j. AIDS. 2005 Jul 1;19(10):1107-8. doi: 10.1097/01.aids.0000174460.24171.0b. AIDS. 2005. PMID: 15958845

5

Atazanavir urinary stones in an HIV-infected patient.

Pacanowski J, Poirier JM, Petit I, Meynard JL, Girard PM. Pacanowski J, et al. AIDS. 2006 Oct 24;20(16):2131. doi: 10.1097/01.aids.0000247571.88256.90. AIDS. 2006. PMID: 17053366 No abstract available.

6

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL; CAMPYL Study Group. Pacanowski J, et al. Clin Infect Dis. 2008 Sep 15;47(6):790-6. doi: 10.1086/591530. Clin Infect Dis. 2008. PMID: 18699745

7

How to improve the quality of a disease management program for HIV-infected patients using a computerized data system. The Saint-Antoine Orchestra program.

Fonquernie F, Lacombe K, Vincensini JP, Boccara F, Clozel S, Ayouch Boda A, Bollens D, Campa P, Pacanowski J, Meynard JL, Meyohas MC, Girard PM. Fonquernie F, et al. Among authors: pacanowski j. AIDS Care. 2010 May;22(5):588-96. doi: 10.1080/09540120903280893. AIDS Care. 2010. PMID: 20401768

8

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.

Valin N, Pacanowski J, Denoeud L, Lacombe K, Lalande V, Fonquernie L, Girard PM, Meynard JL. Valin N, et al. Among authors: pacanowski j. AIDS. 2010 Jun 19;24(10):1519-25. doi: 10.1097/qad.0b013e3283396007. AIDS. 2010. PMID: 20549841

9

Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients.

Pacanowski J, Lacombe K, Campa P, Dabrowska M, Poveda JD, Meynard JL, Poirot JL, Fonquernie L, Girard PM. Pacanowski J, et al. J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):360-7. doi: 10.1097/QAI.0b013e318249de59. J Acquir Immune Defic Syndr. 2012. PMID: 22267015

10

Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy.

Genthon A, Chiarabini T, Baylac P, Valin N, Urbina T, Pacanowski J, Mekinian A, Brissot E, M 'Hammedi-Bouzina F, Lapusan S, Mohty M, Lacombe K, Ingiliz P. Genthon A, et al. Among authors: pacanowski j. Leuk Lymphoma. 2021 Jun;62(6):1502-1505. doi: 10.1080/10428194.2020.1869963. Epub 2021 Jan 8. Leuk Lymphoma. 2021. PMID: 33416421 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page